SG11202109097UA - Materials and methods for enhanced treatment and prevention of biofilms - Google Patents
Materials and methods for enhanced treatment and prevention of biofilmsInfo
- Publication number
- SG11202109097UA SG11202109097UA SG11202109097UA SG11202109097UA SG11202109097UA SG 11202109097U A SG11202109097U A SG 11202109097UA SG 11202109097U A SG11202109097U A SG 11202109097UA SG 11202109097U A SG11202109097U A SG 11202109097UA SG 11202109097U A SG11202109097U A SG 11202109097UA
- Authority
- SG
- Singapore
- Prior art keywords
- biofilms
- prevention
- materials
- methods
- enhanced treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/30—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests characterised by the surfactants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Agronomy & Crop Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pest Control & Pesticides (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962819000P | 2019-03-15 | 2019-03-15 | |
US201962846079P | 2019-05-10 | 2019-05-10 | |
PCT/US2020/022591 WO2020190699A1 (en) | 2019-03-15 | 2020-03-13 | Materials and methods for enhanced treatment and prevention of biofilms |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202109097UA true SG11202109097UA (en) | 2021-09-29 |
Family
ID=72520453
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202109097UA SG11202109097UA (en) | 2019-03-15 | 2020-03-13 | Materials and methods for enhanced treatment and prevention of biofilms |
Country Status (12)
Country | Link |
---|---|
US (1) | US20220142988A1 (en) |
EP (1) | EP3937634A4 (en) |
JP (1) | JP2022525762A (en) |
KR (1) | KR20210129725A (en) |
CN (1) | CN113873883A (en) |
AU (1) | AU2020241243A1 (en) |
BR (1) | BR112021018306A2 (en) |
CA (1) | CA3132821A1 (en) |
IL (1) | IL286437A (en) |
MX (1) | MX2021011147A (en) |
SG (1) | SG11202109097UA (en) |
WO (1) | WO2020190699A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20240188564A1 (en) * | 2021-03-26 | 2024-06-13 | Suncor Energy Inc. | Antibiofilm formulations and methods |
CN117838736B (en) * | 2024-01-29 | 2024-06-14 | 吉林省农业科学院(中国农业科技东北创新中心) | Application of bacillus coagulans JA845 in preparation of medicines for preventing and/or treating atherosclerosis |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI103056B1 (en) * | 1996-08-16 | 1999-04-15 | Orion Yhtymae Oy | Method and test kit for pre-treatment of the sampling surface |
US20020123077A1 (en) * | 2000-09-29 | 2002-09-05 | O'toole George A. | Novel compounds capable of modulating biofilms |
US20070014739A1 (en) * | 2005-07-14 | 2007-01-18 | Eldridge Gary R | Compositions and methods for controlling biofilms and bacterial infections |
JP2012072179A (en) * | 2005-08-30 | 2012-04-12 | Kao Corp | Biofilm inhibitor |
US8357385B2 (en) * | 2008-04-07 | 2013-01-22 | Interface Biologics Inc. | Combination therapy for the treatment of bacterial infections |
CA2744172A1 (en) * | 2008-12-10 | 2010-06-17 | Pan-Eco S.A. | Biosurfactant composition produced by a new bacillus licheniformis strain, uses and products thereof |
US9028878B2 (en) * | 2009-02-03 | 2015-05-12 | Microbion Corporation | Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses |
US8987217B2 (en) * | 2010-01-12 | 2015-03-24 | The General Hospital Corporation | Modified saponins for the treatment of fungal infections |
US20110306569A1 (en) * | 2010-06-11 | 2011-12-15 | Oregon State University | Rhamnolipid biosurfactant from pseudomonas aeruginosa strain ny3 and methods of use |
WO2014120247A1 (en) * | 2013-02-02 | 2014-08-07 | Polytechnic Institute Of New York University | Modified sophorolipids combinations as antimicrobial agents |
CN104233331B (en) * | 2014-09-11 | 2016-06-29 | 南京农业大学 | The sweep-out method of food rustless steel operated implement surface pathogenic bacterium biology Mycoderma |
US20180310566A1 (en) * | 2017-04-29 | 2018-11-01 | Nevada Naturals Inc. | Biofilm Penetrating Compositions and Methods |
-
2020
- 2020-03-13 KR KR1020217032972A patent/KR20210129725A/en unknown
- 2020-03-13 CA CA3132821A patent/CA3132821A1/en active Pending
- 2020-03-13 WO PCT/US2020/022591 patent/WO2020190699A1/en unknown
- 2020-03-13 MX MX2021011147A patent/MX2021011147A/en unknown
- 2020-03-13 SG SG11202109097UA patent/SG11202109097UA/en unknown
- 2020-03-13 US US17/430,021 patent/US20220142988A1/en active Pending
- 2020-03-13 JP JP2021555557A patent/JP2022525762A/en active Pending
- 2020-03-13 CN CN202080021467.8A patent/CN113873883A/en active Pending
- 2020-03-13 EP EP20774334.5A patent/EP3937634A4/en active Pending
- 2020-03-13 AU AU2020241243A patent/AU2020241243A1/en active Pending
- 2020-03-13 BR BR112021018306A patent/BR112021018306A2/en unknown
-
2021
- 2021-09-14 IL IL286437A patent/IL286437A/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL286437A (en) | 2021-10-31 |
WO2020190699A1 (en) | 2020-09-24 |
MX2021011147A (en) | 2021-10-22 |
EP3937634A1 (en) | 2022-01-19 |
CN113873883A (en) | 2021-12-31 |
AU2020241243A1 (en) | 2021-09-09 |
JP2022525762A (en) | 2022-05-19 |
US20220142988A1 (en) | 2022-05-12 |
CA3132821A1 (en) | 2020-09-24 |
EP3937634A4 (en) | 2022-11-09 |
BR112021018306A2 (en) | 2022-01-25 |
KR20210129725A (en) | 2021-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201804514D0 (en) | Treatment of pyroptosis | |
IL292810A (en) | Therapeutic compounds and methods of use | |
IL272321A (en) | Methods and compositions for treatment of amyloid deposition diseases | |
IL291362A (en) | Treatment of syngap1 encephalopathy | |
IL286437A (en) | Materials and methods for enhanced treatment and prevention of biofilms | |
IL286697A (en) | Neuregulin-4 compounds and methods of use | |
IL275925A (en) | Prevention and treatment of organ fibrosis | |
GB201804515D0 (en) | Treatment of necroptosis | |
IL273850A (en) | Compositions and methods for treatment of fibrosis | |
IL276905A (en) | Treatment and prevention of pre-eclampsia | |
GB201916428D0 (en) | Treatment of hydro-carbon-contaminated materials | |
GB201913122D0 (en) | Compositions and methods for treatment of cholangiocarcinoma | |
GB2589398B (en) | Compounds and methods of use | |
EP3377062C0 (en) | Aminonaphthoquinone compounds for treatment and/or prevention of fibrosis diseases | |
IL271727A (en) | Method of treatment and dosage forms thereof | |
GB201907305D0 (en) | Treatment of conditions | |
GB201913124D0 (en) | Compositions and methods for treatment of cholangiocarcinoma | |
GB201913121D0 (en) | Compositions and methods for treatment of cholangiocarcinoma | |
GB201810923D0 (en) | Compositions and method of treatment | |
IL256675A (en) | Methods and compositions for prevention and treatment of pressure ulcers | |
GB202210704D0 (en) | Biofilm prevention and treatment | |
GB201901219D0 (en) | Compositions and methods of treatment | |
IL290983A (en) | Methods of treatment | |
GB201815000D0 (en) | Treatment of hypothroidism and related conditions | |
GB201907609D0 (en) | Treatment and prevention of malaria |